Ortho-McNeil Pharmaceutical
Ortho-McNeil Pharmaceutical
Ortho-McNeil Pharmaceutical (pronunciation: Or-tho-Mc-Neil Phar-ma-ceu-ti-cal) is a leading pharmaceutical company based in the United States. It is a subsidiary of Johnson & Johnson, one of the world's largest and most diverse healthcare companies.
Etymology
The name "Ortho-McNeil" is derived from the names of its founders, who established the company in the early 20th century. The term "Pharmaceutical" refers to the company's primary business of developing, manufacturing, and marketing drugs and medicines.
History
Ortho-McNeil Pharmaceutical was founded in 1931 as a joint venture between two pharmaceutical pioneers, Ortho Pharmaceutical and McNeil Laboratories. The company has since grown to become a major player in the global pharmaceutical industry, with a wide range of products in various therapeutic areas.
Products
Ortho-McNeil Pharmaceutical is known for its diverse portfolio of drugs and medicines, which includes treatments for conditions such as diabetes, hypertension, and infectious diseases. Some of its most well-known products include Levaquin, a broad-spectrum antibiotic, and Topamax, an anticonvulsant used to treat epilepsy and prevent migraines.
Related Terms
External links
- Medical encyclopedia article on Ortho-McNeil Pharmaceutical
- Wikipedia's article - Ortho-McNeil Pharmaceutical
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski